Can Vaccine Development Be Safely Accelerated?
March 26, 2020 - BioPharm International Can Vaccine Development Be Safely Accelerated? Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe. …

Manufacturing of Vaccines and Viral Vectors
March 26, 2020 - GE Healthcare Life Sciences With the pandemic outbreak of COVID-19, there is intense focus on developing a vaccine. However, the challenge not only lies in developing a vaccine but also i…

Buffer Management Solutions for Large-Scale Biomanufacturing
March 26, 2020 - GE Healthcare Life Sciences Learn how different approaches can resolve buffer management challenges in large-scale biomanufacturing. This article discusses solutions such as inline conditioni…

The Future of Biopharma
March 26, 2020 - GE Healthcare Life Sciences In this article, Günter Jagschies, former Senior Director, Strategic Consumer Relations at GE Healthcare, highlights the evolution of the biopharma industry. Gün…

GE Expands Offering for ReadyToProcess™ Columns
March 26, 2020 - GE Healthcare Life Sciences ReadyToProcess columns are offered in seven inner diameters to meet the needs of upstream production. You can enjoy the flexibility of using our prepacked ReadyToP…

The Path to High-Quality Immunoassay Reagents
March 26, 2020 - GE Healthcare Life Sciences How Biacore surface plasmon resonance is shaping today’s assay development and selection of diagnostic reagents. Click here to learn more >>

Evaluation of Hek293 Cell Growth and Adenovirus Productivity in H…
March 26, 2020 - GE Healthcare Life Sciences This application note demonstrates growth and adenovirus productivity of HEK293 cells and explores the key factors involved in the optimization of cell culture per…

Getting Ahead of the Game in Cell and Gene Therapy
March 12, 2020 - GE Healthcare Life Sciences Successes in the clinic have placed many cell and gene therapies on an accelerated route to market. But unless developers consider, at an early stage, how they might…

GE Healthcare Life Sciences and GoSilico Agree to Co-market Chrom…
March 12, 2020 - GE Healthcare Life Sciences The agreement facilitates the adoption of ChromX™ by scientists and users of resins, columns, and chromatography systems into their downstream process-developmen…

The Evolution of Supply Chain Security: Increasing Focus on Raw M…
March 12, 2020 - GE Healthcare Life Sciences An increase in the development of biological and patient-specific drugs has also reinforced the demand for heightened raw material control. Click here to read …

Next Page